Resources from the same session
4715 - Pembrolizumab for Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC): Post Hoc Analyses of Treatment Options From the Phase 3 KEYNOTE-040 Trial
Presenter: Christophe Le Tourneau
Session: Poster Discussion session - Head and neck cancers
Resources:
Abstract
1719 - Results of a Phase II study evaluating monalizumab in combination with cetuximab in previously treated recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
Presenter: Jérôme Fayette
Session: Poster Discussion session - Head and neck cancers
Resources:
Abstract
3560 - Phase 1b/2, open label, multicenter study of intratumoral SD-101 in combination with pembrolizumab in anti-PD-1 treatment naïve patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC)
Presenter: Ezra Cohen
Session: Poster Discussion session - Head and neck cancers
Resources:
Abstract
2434 - Comparison of Patient Populations Identified by Different PD-L1 Assays in Head and Neck Squamous Cell Carcinoma (HNSCC)
Presenter: Marietta Scott
Session: Poster Discussion session - Head and neck cancers
Resources:
Abstract
1490 - Predictor of Effectiveness of Treatment Intensification on Overall Survival in Head and Neck Cancer (HNC)
Presenter: Kaveh Zakeri
Session: Poster Discussion session - Head and neck cancers
Resources:
Abstract
5466 - Genomics features (GF) and integration with MRI radiomics features (RF) to develop a prognostic model in oral cavity squamous cell carcinoma (OSCC)
Presenter: Stefano Cavalieri
Session: Poster Discussion session - Head and neck cancers
Resources:
Abstract
Poster Discussion session - Head and neck cancers - Invited Discussant 1051PD, 1052PD and 1053PD
Presenter: Hisham Mehanna
Session: Poster Discussion session - Head and neck cancers
Resources:
Slides
Webcast
4533 - Concurrent cisplatin and Dose escalation with Intensity-modulated radiotherapy (IMRT) versus conventional chemo-radiotherapy for locally advanced (LA) head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial
Presenter: Yungan Tao
Session: Poster Discussion session - Head and neck cancers
Resources:
Abstract
4198 - Surrogates of immunologic cell death (ICD) and chemoradiotherapy outcomes in head and neck squamous cell carcinoma (HNSCC).
Presenter: George Koutsodontis
Session: Poster Discussion session - Head and neck cancers
Resources:
Abstract
4702 - Phase I experience with rogaratinib in patients with head and neck cancer selected based on FGFR mRNA overexpression
Presenter: Markus Joerger
Session: Poster Discussion session - Head and neck cancers
Resources:
Abstract